ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag academia books drug development industry

Industry vs Academia
The Scientist Staff | Apr 15, 2001 | 10+ min read
To conduct this survey, The Scientist invited 1800 readers via E-mail to respond to a web-based survey form. There were a total of 220 responses from March 2 to 12, 2001, a response rate of 12.2%. Have you held research positions in both academia and industry? (Positions may include graduate research, industrial internships, or any other research positions - paid or unpaid - in both work environments).   Percent Count Answers 72.6% 159/219 Yes 27.4% 60/219 No
Best Places to Work Academia, 2012
The Scientist | Aug 1, 2012 | 9 min read
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
Tag, You're It
Carina Storrs | Feb 1, 2014 | 7 min read
A guide to DNA-encoded libraries for drug discovery
Opinion: Bias Is Unavoidable
Lisa Cosgrove | Aug 7, 2012 | 4 min read
Simply disclosing conflicts of interest is not enough.
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
National AIDS Task Force Expected To Accelerate Drug Development
Franklin Hoke | Feb 6, 1994 | 8 min read
Bench scientists will play a major role in an ambitious effort to streamline the campaign against HIV The soon-to-be-appointed National Task Force on AIDS Drug Development may have a strong, positive impact on the research and development of antiviral therapies to counter HIV infection, say industry and academic scientists, government officials organizing the task force, and members of the AIDS-affected community. Key to the task
Drug Companies Must Adapt to the 'Bioburst' Era
Richard Noel Re | Oct 4, 1987 | 5 min read
“Bioburst” as the name Richard Noel Re gives to the revolution now taking place in molecular biology. In his book Bioburst: The Impact of Modern Biology on the Affairs of Man (Louisiana State University Press, 1986), Re discusses how that revolution will permeate contemporary life. He uses the discovery of cyclosporin A to illustrate the new flexibility needed in the pharmaceutical industry to deal with this revolution. The excerpt below is taken from the book. Chance favors the
The Industry Roads Less Taken
Toby Freedman | Jun 1, 2008 | 6 min read
Four high-paying, in-demand, industry jobs scientists often overlook, and tips on how to get in.
Innovation Nation
Megan Scudellari | Jul 1, 2013 | 8 min read
Already a world leader in high-tech entrepreneurship, Israel is now flexing its biotech muscles.
The Life Science Industry Awards
Jeffrey Perkel | Dec 5, 2004 | 7 min read
In terms of innovation, the life science industry has few peers.

Run a Search

ADVERTISEMENT